Text this

Text this: Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture

Cannot write session to /tmp/vufind_sessions/sess_5vj3a7l03e5u6n5ld5u432gq47